期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
Algorithms for treatment of diffuse bleeding in cardiac surgery are based on intervention thresholds of coagulation tests, such as rotational thromboe......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (3)
Although certain risk factors have been associated with morbidity and mortality, validated emergency department (ED) derived risk prediction models sp......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (3)
The decision by pulmonary embolism response teams (PERTs) to utilize anticoagulation (AC) with or without systemic thrombolysis (ST) or catheter-direc......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (1)
Bone marrow biopsies are largely used for the diagnosis and prognostic of various hematological diseases. Complications are rare but can be as serious......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (2)
Therapeutic advances have resulted in increased life expectancy in patients with hemophilia. Consequently, the prevalence of coronary artery disease i......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
Anticoagulant therapy is a cornerstone treatment for coronavirus disease 2019 (COVID-19) due to the high rates of thromboembolic complications associa......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
There is significant overlap between knowledge and its clinical application in stroke and thrombosis & vascular medicine. Formal integration of tr......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
Complications following thrombolysis for stroke are well documented, and mostly concentrated on haemorrhage. However, the consequences of patients who......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (2)
Anticoagulation therapy is prescribed for the prevention of recurrence in patients with venous thromboembolism, which could be temporarily interrupted......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (4)
The complement system (CS) plays a pivotal role in Coronavirus disease 2019 (COVID-19) pathophysiology. The objective of this study was to provide a c......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (3)
Background Anastrozole is commonly used for the treatment of oestrogen receptor (ER)-positive breast cancer but can increase thromboembolic risk. It i......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
Limited data exists regarding the clinical outcomes of andexanet alfa and four factor prothrombin complex concentrate (4F-PCC) for reversal of apixaba......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (2)
In Taiwan, the outcomes of acute limb ischemia have yet to be investigated in a standardized manner. In this study, we compared the safety, feasibilit......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (2)
Patients with COVID-19 are at higher risk of thrombosis due to the inflammatory nature of their disease. A higher-intensity approach to pharmacologic ......
